Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,632.19
(
-0.61%
)
US TECH 100
23,737.60
(
-0.64%
)
Dow Jones
46,558.47
(
-0.26%
)
Brent Oil
102.00
(
0.76%
)
Bitcoin
73,745.99
(
1.29%
)
News Focus
News Focus
Post# of 257244
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: turtlepower post# 88895

Monday, 01/31/2011 11:46:36 AM

Monday, January 31, 2011 11:46:36 AM

Post# of 257244
Allergan Inc (AGN.N) bought co-promotion rights on Map Pharmaceuticals Inc's (MAPP.O) experimental treatment for acute migraine for $60 million in upfront payment, in a move to expand its migraine franchise.

The two companies will co-promote the drug, Levadex, to neurologists and pain specialists in the United States, pending regulatory approval.

http://www.reuters.com/article/2011/01/31/allergan-idUSSGE70U0CE20110131?feedType=RSS&feedName=rbssHealthcareNews&rpc=43
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now